BioAge Labs, Inc. (BIOA) vs Alpha Teknova, Inc. (TKNO)
- BioAge Labs, Inc. BIOA 4.82 −9.91%
- Alpha Teknova, Inc. TKNO 7.08 −6.84%
BioAge Labs, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $408.0M against $245.6M — 1.7× the size. Alpha Teknova, Inc. has the higher net margin (−38.4% vs −912.3%) and the higher return on invested capital (−16.9% vs −118.3%). Across the 16 metrics below, Alpha Teknova, Inc. leads on 10 and BioAge Labs, Inc. on 6.
Valuation
Profitability
| Metric | BIOA | TKNO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 34.60% | 53.94% |
| Operating margin | (1,026.28%) | (36.19%) | 0.00% |
| Net margin | (912.25%) | (38.37%) | 0.00% |
| Free cash flow margin | (2,345.11%) | (16.83%) | 0.00% |
| Return on equity | (28.21%) | (24.19%) | (0.40%) |
| Return on assets | (26.27%) | (16.25%) | (3.32%) |
| Return on invested capital | (118.25%) | (16.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack